Titus Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$326K Sell
3,573
-166
-4% -$14.7K 0.16% 102
2022
Q1
$307K Buy
3,739
+484
+15% +$38.2K 0.14% 120
2021
Q4
$249K Sell
3,255
-215
-6% -$17.1K 0.11% 140
2021
Q3
$261K Buy
3,470
+761
+28% +$57.9K 0.14% 126
2021
Q2
$211K Sell
2,709
-183
-6% -$13.6K 0.11% 144
2021
Q1
$213K Sell
2,892
-521
-15% -$38.4K 0.12% 133
2020
Q4
$266K Buy
3,413
+376
+12% +$28.8K 0.16% 102
2020
Q3
$240K Buy
+3,037
New +$238K 0.17% 103
2020
Q1
Sell
-2,386
Closed -$207K 112
2019
Q4
$207K Buy
+2,386
New +$196K 0.21% 102

Other funds holding MRK

Titus Wealth Management's MRK Position: Q2 2022 in Review

Titus Wealth Management reduced its Merck (MRK) stake by 4.4% in Q2 2022, selling an estimated $14.7K and leaving 3,573 shares worth $326K. The position accounts for 0.16% of the portfolio, ranked #102.

Titus Wealth Management first reported a position in MRK in Q4 2019 and has held it in 9 quarters since. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

  • Titus Wealth Management held 3,573 shares of Merck worth $326K as of Q2 2022.
  • Titus Wealth Management sold 166 Merck shares in Q2 2022, an estimated $14.7K.
  • Merck made up 0.16% of Titus Wealth Management's portfolio in Q2 2022, its #102 holding.
  • Titus Wealth Management first reported a position in Merck in Q4 2019 and has held it in 9 quarters since.
  • 3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Titus Wealth Management's 13F filing for Q2 2022, filed 9 Nov 2022.